Doubt it because it would not make logical sense given that their material large investors are still present and their promising pipeline, especially for lymphoma & pancreatic cancer.
They won't let it delist. If they were going to do that they wouldn't have gone through the trouble of approving the reverse split. It doesn't take long to initiate the reverse split. The end of January date is because share price needs to be over $1 for ten consecutive trading days to regain compliance. It's not the date they need to effect the reverse split. They technically have until the middle of February.
News 
Market Data 
Discover 
AI
